A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
Clinical trial NCT04414163 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04414163
- Sponsor
- ImmuneOncia Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-27
- Primary completion
- 2024-07-23
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.